• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比色法测定尿液和粪便中的5-氨基水杨酸及其N-乙酰化代谢物。

Colorimetric determination of 5-aminosalicylic acid and its N-acetylated metabolite on urine and feces.

作者信息

Pieniaszek H J

出版信息

Res Commun Chem Pathol Pharmacol. 1975 Nov;12(3):571-81.

PMID:747
Abstract

A simple and convenient colorimetric method is described for the quantitative determination of 5-aminosalicylic acid (5-ASA) and N-acetyl-5-ASA in urine and feces after oral administration of salicylazosulfa-pyridine (SASP), the drug of choice in the treatment of ulcerative colitis. N-acetyl-5-ASA is extracted directly from the acidified biological specimen, deacetylated, and the liberated 5-ASA subjected to a modified Bratton-Marshall reaction. The 5-ASA present in the specimen must be acetylated with acetic anhydride prior to extraction. The violet colored product of the Bratton-Marshall reaction has a lambdamax of 560 nm and conforms to Beer's law over the concentration range of 0-70 umg/ml. Average recoveries (+/- S.D., N = 6) OF 5-ASA added to rat and human urine and rat fecal homogenates were 91.6 +/- 4.9%, 102 +/- 6.0%, and 71.0 +/- 4.8%, respectively. Interference by SASP and its sulfapyridine metabolities is negligible. As demonstrated, the colorimetric method is of sufficient sensitivity for application in most metabolic and pharmacokinetic studies conducted with SASP in laboratory animals and man.

摘要

本文描述了一种简单便捷的比色法,用于定量测定口服柳氮磺胺吡啶(SASP,治疗溃疡性结肠炎的首选药物)后尿液和粪便中的5-氨基水杨酸(5-ASA)和N-乙酰-5-ASA。N-乙酰-5-ASA直接从酸化的生物样本中提取,脱乙酰化,然后将释放出的5-ASA进行改良的Bratton-Marshall反应。样本中存在的5-ASA在提取前必须用乙酸酐乙酰化。Bratton-Marshall反应产生的紫色产物的最大吸收波长为560 nm,在0-70 μg/ml的浓度范围内符合比尔定律。添加到大鼠和人尿液以及大鼠粪便匀浆中的5-ASA的平均回收率(±标准差,N = 6)分别为91.6±4.9%、102±6.0%和71.0±4.8%。SASP及其磺胺吡啶代谢物的干扰可忽略不计。结果表明,该比色法灵敏度足以应用于大多数在实验动物和人体中进行的SASP代谢和药代动力学研究。

相似文献

1
Colorimetric determination of 5-aminosalicylic acid and its N-acetylated metabolite on urine and feces.比色法测定尿液和粪便中的5-氨基水杨酸及其N-乙酰化代谢物。
Res Commun Chem Pathol Pharmacol. 1975 Nov;12(3):571-81.
2
Determination of free and acetylated 5-aminosalicylic acid in serum and urine after administration of salicylazosulphapyridine.柳氮磺胺吡啶给药后血清和尿液中游离及乙酰化5-氨基水杨酸的测定
Acta Pharm Suec. 1973 May;10(2):153-5.
3
Estimation of 5-aminosalicylic acid and its metabolite in human serum by front-face fluorometry: a simple and sensitive method.采用表面荧光法测定人血清中5-氨基水杨酸及其代谢产物:一种简单灵敏的方法。
J Lab Clin Med. 1990 Jul;116(1):45-50.
4
Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.与柳氮磺胺吡啶及其代谢产物磺胺吡啶相比,溃疡性结肠炎新型治疗药物BX661A对多形核白细胞趋化性和活性氧生成的影响。
Arzneimittelforschung. 1998 Dec;48(12):1163-7.
5
5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.含5-氨基水杨酸的药物。人体中的递送、转归及可能的临床意义。
Dan Med Bull. 2000 Feb;47(1):20-41.
6
5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa.
Eur J Clin Pharmacol. 1986;31(1):23-6. doi: 10.1007/BF00870980.
7
Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis.
Scand J Gastroenterol. 1986 Aug;21(6):693-700. doi: 10.3109/00365528609011102.
8
Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.通过研究BX661A对葡聚糖硫酸钠诱导的大鼠溃疡性结肠炎的治疗效果来确定其活性部分,BX661A是一种用于治疗溃疡性结肠炎的新型治疗药物。
Arzneimittelforschung. 1998 Nov;48(11):1091-6.
9
Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.溃疡性结肠炎新型治疗药物BX661A与柳氮磺胺吡啶及其代谢产物磺胺吡啶相比对活性氧的影响
Arzneimittelforschung. 1998 Oct;48(10):1007-11.
10
Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin).肠道转运时间对柳氮磺胺吡啶(水杨酸偶氮磺胺吡啶)偶氮还原的影响。
Gut. 1979 Apr;20(4):300-4. doi: 10.1136/gut.20.4.300.

引用本文的文献

1
Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide.两种新型柳氮磺胺吡啶类似物——依沙拉嗪和巴柳氮的研究。
Dig Dis Sci. 1983 Jul;28(7):609-15. doi: 10.1007/BF01299921.
2
Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.磺胺吡啶、5-氨基水杨酸和安慰剂对特发性直肠炎患者的影响:一项确定柳氮磺胺吡啶活性治疗成分的研究。
Gut. 1980 Jul;21(7):632-5. doi: 10.1136/gut.21.7.632.
3
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).
用于治疗胃肠道疾病的药物的临床药代动力学(第二部分)。
Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.
4
Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin).肠道转运时间对柳氮磺胺吡啶(水杨酸偶氮磺胺吡啶)偶氮还原的影响。
Gut. 1979 Apr;20(4):300-4. doi: 10.1136/gut.20.4.300.